- In March 2025, Stryker, announced the expansion of its 3D-printed Tritanium portfolio with new porous implant designs aimed at enhancing bone ingrowth and accelerating fusion in spinal surgeries. This development underscores Stryker's commitment to leveraging additive manufacturing technologies to improve the biomechanical performance and patient outcomes of bone healing implants
- In March 2025, Medtronic received regulatory approval for its latest generation robotic-assisted surgery platform, which features enhanced precision and navigation capabilities for the placement of bone healing implants in complex trauma and spine procedures. This advancement highlights the increasing integration of robotics in orthopedic surgery to improve accuracy, reduce invasiveness, and potentially shorten patient recovery times
- In March 2025, Johnson & Johnson (DePuy Synthes) launched a new bioresorbable screw system made from advanced polymer materials designed for fracture fixation in pediatric patients. These implants gradually dissolve as the bone heals, eliminating the need for a second surgery for removal, addressing a significant need in pediatric orthopedics and demonstrating a focus on patient-centric solutions
- In February 2025, Zimmer Biomet announced a strategic partnership with a leading biotech firm to develop and commercialize novel bone growth factors that can be integrated with their existing portfolio of bone healing implants. This collaboration aims to enhance the biological healing process and improve outcomes in challenging fracture cases and bone regeneration procedures
- In January 2025, Smith+Nephew introduced a new generation of smart fracture fixation devices equipped with integrated sensors to monitor the healing progress in real-time. These devices can wirelessly transmit data to clinicians, allowing for more personalized post-operative care and early detection of potential complications, representing a step towards connected and data-driven orthopedic solutions
